Clinical Trial Update: Evaluation of Oral Activated Charcoal on Antimalarial Drug's Ability to Kill Parasites in Malian Children With Malaria [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating oral activated charcoal to assess its impact on the effectiveness of an antimalarial drug in Malian children with malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Malaria, Severe Malaria | Phase 2 | Status: COMPLETED | Results posted: 2018-02-06